Key Takeaways Gepotidacin is the first new class of oral antibiotics for uUTIs in nearly 30 years, addressing rising drug resistance. Phase 3 trials showed gepotidacin's non-inferiority to ...

Antibiotic resistance is one of the most urgent problems facing humanity, but it’s been decades since we last developed a new class of these drugs. That could all be about to change thanks to ...

Now, scientists have discovered a new antibiotic —a lasso peptide called lariocidin—and it has a distinct mode of action that makes it the first of an entirely new class of antibiotic compound ...

Ushering in a new class of antibiotics, the U.S. FDA approved GSK plc’s gepotidacin for use in uncomplicated urinary tract infections (uUTIs). Branded Blujepa, the oral triazaacenaphthylene bacterial ...